Kingsview Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Kingsview Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$514K	Sell	915 -45	-5%	-$28.9K	0.01%	894
2025 Q4	$649K	Sell	960 -20	-2%	-$13.6K	0.01%	764
2025 Q3	$626K	Sell	980 -16	-2%	-$9.71K	0.01%	735
2025 Q2	$534K	Hold	996	–	–	0.01%	746
2025 Q1	$418K	Sell	996 -10	-1%	-$4.34K	0.01%	781
2024 Q4	$416K	Buy	1,006 +3	+0.3%	+$1.32K	0.01%	802
2024 Q3	$507K	Buy	+1,003	New	+$487K	0.01%	718
2022 Q2	–	Sell	-368	Closed	-$201K	–	858
2022 Q1	$201K	Sell	368 -450	-55%	-$237K	0.01%	818
2021 Q4	$539K	Sell	818 -933	-53%	-$586K	0.02%	553
2021 Q3	$1.09M	Sell	1,751 -25	-1%	-$16.8K	0.05%	346
2021 Q2	$1.14M	Buy	1,776 +187	+12%	+$103K	0.06%	344
2021 Q1	$773K	Buy	+1,589	New	+$796K	0.04%	408

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kingsview Wealth Management's IDXX Position: Q1 2026 in Review

Kingsview Wealth Management reduced its Idexx Laboratories (IDXX) stake by 4.7% in Q1 2026, selling an estimated $28.9K and leaving 915 shares worth $514K. The position accounts for 0.01% of the portfolio, ranked #894.

Kingsview Wealth Management first reported a position in IDXX in Q1 2021 and has held it in 12 quarters since. The position peaked at $1.14M in Q2 2021. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Kingsview Wealth Management held 915 shares of Idexx Laboratories worth $514K as of Q1 2026.
Kingsview Wealth Management sold 45 Idexx Laboratories shares in Q1 2026, an estimated $28.9K.
Idexx Laboratories made up 0.01% of Kingsview Wealth Management's portfolio in Q1 2026, its #894 holding.
Kingsview Wealth Management first reported a position in Idexx Laboratories in Q1 2021 and has held it in 12 quarters since.
Kingsview Wealth Management's Idexx Laboratories position peaked at $1.14M in Q2 2021.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Kingsview Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.